In this respect, the direct link between the amino acid transport activity of xCT and retinopathy among HIV-infected individuals suggests that targeting xCT may represent a promising new strategy for ameliorating this disease in high-risk groups (Bridges et al., 2004; Butler and Thorne, 2012). This evidence concerns the gene SLC7A11 and retinal disorder.